David G. Miller, RPh, on the Drug Quality and Security Act

Published Online: Tuesday, November 12, 2013
In this video, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists (IACP), discusses H.R. 3204, the Drug Quality and Security Act, which passed the House of Representatives on September 25, 2013. Miller explains that IACP opposes the bill because it reaffirms section 503A of the Federal Food, Drug, and Cosmetic Act rather than fixing its problems. This video was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues